Tiagabine.
Leach
J P
JP
University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK.
Brodie
M J
MJ
D000927:Anticonvulsants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D004828:Epilepsies, Partial / Q000188:drug therapy*; D006801:Humans; D014179:Neurotransmitter Uptake Inhibitors / Q000627:therapeutic use; D009557:Nipecotic Acids / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D000078308:Tiagabine; D005680:gamma-Aminobutyric Acid / Q000502:physiology
D000927:Anticonvulsants; D014179:Neurotransmitter Uptake Inhibitors; D009557:Nipecotic Acids; D005680:gamma-Aminobutyric Acid; D000078308:Tiagabine